Luis Fayad

The University of Texas MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

(2023)10.1158/2643-3230.c.6550995

Top 100%

0DataRank

Top 100%0 citations

Qing Deng, Mario L. Marques‐Piubelli, Enyu Dai, Minghao Dang, Man Chun John +29 more

Papers

Driven by 24 papers — median percentile 0. Top paper: “Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma”.

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0177

N/A

3.4DataRank · unranked

75 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Ibrutinib With Rituximab in First-Line Treatment of Older Patients With Mantle Cell Lymphoma

Journal of Clinical Oncology(2021)10.1200/jco.21.01797

N/A

2.5DataRank · unranked

83 citations

Shuangtao Zhao, Hun Ju Lee, Holly A. Hill, Chi Young Ok, Rashmi Kanagal‐Shamanna +22 more

Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma

Journal of Clinical Oncology(2022)10.1200/jco.22.00597

N/A

1.7DataRank · unranked

58 citations

R. Eric Davis, Lei Feng, Fredrick B. Hagemeister, Raphaël Steiner, Hun Ju Lee +24 more

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00638-0

N/A

1.5DataRank · unranked

56 citations

Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Loretta J. Nastoupil, Luis Fayad +32 more

Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1215

N/A

1.3DataRank · unranked

41 citations

Haeseong Park, S. Greg Call, Kiran Madwani, Yasuhiro Oki, Vivek Subbiah +17 more

Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial

The Lancet Haematology(2024)10.1016/s2352-3026(24)00133-9

N/A

0.833DataRank · unranked

29 citations

Jie Xu, Manoop S. Bhutani, Paolo Strati, Penny Q Fang, Susan Wu +22 more

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Blood Advances(2022)10.1182/bloodadvances.2022008174

N/A

0.629DataRank · unranked

15 citations

Stefan Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu +16 more

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

Blood Advances(2025)10.1182/bloodadvances.2025016483

N/A

0.241DataRank · unranked

4 citations

Lei Feng, Jason R. Westin, Fredrick B. Hagemeister, Hun Ju Lee, Luis Fayad +16 more

Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy

Haematologica(2023)10.3324/haematol.2023.284453

N/A

0DataRank · unranked

4 citations

Naishu Kui, Ryan Sun, Jason R. Westin, Raphaël Steiner, Ranjit Nair +16 more

Six Years Follow up of Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hyper CVAD/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial

Blood(2023)10.1182/blood-2023-181312

N/A

0DataRank · unranked

1 citations

Hun Ju Lee, Jason R. Westin, Loretta J. Nastoupil, Luis Fayad, Ranjit Nair +14 more

Data from Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

(2023)10.1158/2643-3230.c.6550995

Top 100%

0DataRank

Top 100%0 citations

Qing Deng, Mario L. Marques‐Piubelli, Enyu Dai, Minghao Dang, Man Chun John +29 more

Data from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

(2023)10.1158/2643-3230.c.6550812.v1

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?

Advances in Radiation Oncology(2024)10.1016/j.adro.2024.101650

N/A

0DataRank · unranked

1 citations

Sonal S. Noticewala, Susan Wu, Jillian R. Gunther, Ethan B. Ludmir, L. Jeffrey Medeiros +15 more

Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Blood(2024)10.1182/blood-2024-205196

N/A

0DataRank · unranked

4 citations

Dai Chihara, Luis Fayad, Sattva S. Neelapu, Sairah Ahmed, Frederick Hagemeister +11 more

Peripheral Blood CAR T-Cell Level Using a Clia-Validated Assay Is Prognostic for Treatment Response and Icans in Large B-Cell Lymphoma

Blood(2024)10.1182/blood-2024-208300

N/A

0DataRank · unranked

0 citations

Naishu Kui, Ryan Sun, Eslam Aboismail, Sanjit O. Tewari, Ajlan Al Zaki +26 more

Interim PET-Adapted De-Escalation Chemotherapy Regimen for Advanced Stage Classical Hodgkin Lymphoma Using Brentuximab Vedotin, Pembrolizumab, Doxorubicin, and Dacarbazine: Phase 2 Safety and Efficacy Study

Blood(2024)10.1182/blood-2024-212005

N/A

0DataRank · unranked

0 citations

Gregory Ravizzini, Eslam Aboismail, Jenna M. Wixom, Jared Henderson, Luis Fayad +11 more

Frontline acalabrutinib, lenalidomide and rituximab for advanced stage follicular lymphoma with high tumor burden: phase II trial

Nature Communications(2025)10.1038/s41467-025-62509-z

N/A

0DataRank · unranked

4 citations

Lei Feng, Jason R. Westin, Ranjit Nair, Luis Fayad, Maria Alma Rodriguez +14 more

Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET–CT-documented First Remission

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.02.008

N/A

0DataRank · unranked

5 citations

Jillian R. Gunther, Penny Fang, Sarah A. Milgrom, Brinda Rao Korivi, Corey T. Jensen +16 more

Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8011

N/A

0DataRank · unranked

22 citations

Fateeha Furqan, Jason R. Westin, Luis Fayad, Sairah Ahmed, Hun Ju Lee +15 more

A phase 2, open-label, multicenter study of the long-term safety of siltuximab (an anti-interleukin-6 monoclonal antibody) in patients with multicentric Castleman disease

UNC Libraries(2020)10.17615/tfn8-cp59

N/A

0DataRank · unranked

0 citations

Ming Qi, Peter M. Voorhees, Frits van Rhee, Razelle Kurzrock, Luis Fayad +5 more

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.28.461858

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil Patel, Kartik Devashish +32 more

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Haematologica(2022)10.3324/haematol.2022.281954

N/A

0DataRank · unranked

15 citations

Sushanth Gouni, Jason R. Westin, Lei Feng, Haleigh Mistry, Raphaël Steiner +16 more

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010653

N/A

0DataRank · unranked

44 citations

Andrew Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun +23 more

Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.04.006

N/A

0DataRank · unranked

13 citations

Sairah Ahmed, Sheeba K. Thomas, Lan Sun Wang, Khalis Mustafayev, Luis Fayad +4 more

Luis Fayad

Indexed papers

Top data-sharing exemplar

Papers